VENLAFAXINE Drug Patent Profile
✉ Email this page to a colleague
When do Venlafaxine patents expire, and what generic alternatives are available?
Venlafaxine is a drug marketed by Almatica, Alembic, Anchen Pharms, Annora Pharma, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Granules, Intellipharmaceutics, Inventia Hlthcare, Macleods Pharms Ltd, Norvium Bioscience, Nostrum Pharms Llc, Orbion Pharms, Teva, Torrent, Valeant Pharms North, Wockhardt Bio Ag, Yichang Humanwell, Zydus Pharms Usa Inc, Ajanta Pharma Ltd, Alkem Labs Ltd, Appco, Ascent Pharms Inc, Cadila Pharms Ltd, Dexcel, Nostrum Labs Inc, Osmotica Pharm Us, Sun Pharm, Swiss Pharm, Unique, Zydus Pharms, Alembic Pharms Ltd, Amneal Pharms, Aurobindo Pharma, Chartwell Rx, Heritage, Pliva Hrvatska Doo, Prinston Inc, Sun Pharm Inds Inc, Yaopharma Co Ltd, and Zydus Pharms Usa. and is included in forty-six NDAs. There is one patent protecting this drug.
The generic ingredient in VENLAFAXINE is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Venlafaxine
A generic version of VENLAFAXINE was approved as venlafaxine hydrochloride by TEVA on August 3rd, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VENLAFAXINE?
- What are the global sales for VENLAFAXINE?
- What is Average Wholesale Price for VENLAFAXINE?
Summary for VENLAFAXINE
| US Patents: | 0 |
| Applicants: | 41 |
| NDAs: | 46 |
| Drug Prices: | Drug price information for VENLAFAXINE |
| Drug Sales Revenues: | Drug sales revenues for VENLAFAXINE |
| What excipients (inactive ingredients) are in VENLAFAXINE? | VENLAFAXINE excipients list |
| DailyMed Link: | VENLAFAXINE at DailyMed |
See drug prices for VENLAFAXINE
US Patents and Regulatory Information for VENLAFAXINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cadila Pharms Ltd | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211323-003 | Aug 29, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Amneal Pharms | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 079098-001 | May 11, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Torrent | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 090899-001 | Jun 1, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Nostrum Pharms Llc | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 200430-001 | Apr 4, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Yaopharma Co Ltd | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 202036-003 | May 28, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Swiss Pharm | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 214423-001 | Jan 4, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
